Screener
Arcutis Biotherapeutics, Inc. ARQT Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 113,432 | 96,115 | 227,919 | 186,490 |
| Income (loss) from operations | 16,429 | (14,611) | 7,340 | (39,140) |
| Other income (expense): | ||||
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
| Interest expense | (3,406) | (3,029) | (7,774) | (6,011) |
| Other income (expense), net | (157) | 20 | (177) | 213 |
| Total other income (expense) | (1,284) | (933) | (3,397) | (1,185) |
| Income (loss) before income taxes | 15,145 | (15,544) | 3,943 | (40,325) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s interest income?
- Arcutis Biotherapeutics, Inc. (ARQT) reported interest income of $2.28M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s interest income changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s interest income increased by 9.8% year-over-year, from $2.08M to $2.28M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Arcutis Biotherapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude